ChartPros Market Insights

Hormel Hits the Mark… But Management’s Tone Raises Eyebrows

Hormel met earnings expectations, but management’s cautionary tone on supply chain issues raised new questions.

Despite the warning, shares rose—so what is the chart really saying?

Crude Oil Back in the Spotlight — But the Chart Isn’t Exactly Bullish

Crude price continues to stall near the $65 mark. Some analysts are eyeing a potential slide into the low $50s — or even lower.

We’ll let the chart do the talking as we analyze key levels and price action structure that could hint at what’s next.

NVIDIA Reports After the Bell—But Is the Chart Flashing Caution?

While the AI hype train is still rolling, the chart may be signaling a different story. 

We'll analyze NVDA’s price action to uncover critical levels that could dictate whether momentum continues—or stalls—this week and beyond.

AMD’s AI Pivot: Breakout Move or Just Background Noise?

After trailing NVIDIA in the AI spotlight, AMD is now carving its own path — not as a rival, but as a strategic complement. With a 15% rebound in the past month, momentum is on its side.

But the real question remains: Will the price action confirm a true shift, or is this just another shadow play?

Booz Allen Takes a Hit as Budget Cuts Cloud Outlook

The company matched earnings forecasts, but cautious guidance and federal budget pressures sent shares tumbling 17 percent today.

Best Buy (BBY) reports earnings May 29 

Analysts are already sounding the alarm but we’ll let the chart do the talking—price action tells the real story.

Medtronic (MDT) beat on earnings and unveiled plans to spin off its diabetes unit into a standalone company — but the market wasn’t impressed.

Shares slid 2% in after-hours trading, raising eyebrows. Did traders just shrug off the news… or are they seeing something management isn’t?

We’ll break down the price action and let the chart do the talking.

Keysight (KEYS) Surges Post-Earnings — Momentum Traders Take Note

Shares popped nearly 5% after hours Tuesday on an earnings beat, drawing immediate attention.

With volume rising and key levels in play, the next move could come fast.

ChartPros filed U.S. Patent Application 63/808,216 for its NeuroTrading Method™ 

The system is an innovative framework that integrates quantitative price action technical  analysis with evidence based mental performance training to strengthen execution and ultimately consistency for traders and investors.

“Strategy wins only when mindset cooperates,” says founder and certified mental performance coach Tom Winterstein.

Have you ever felt stuck in the cycle of overthinking, second-guessing, or somehow missing great trades? You’re not alone. Most traders lose not because of bad strategy - but because of a lack of clarity and confidence.

Here’s how you can fix it...

ChartPros Patent-Pending "NeuroTrading Method™” is the ultimate fusion between the pillars of mental performance and price action mastery, empowering traders to overcome emotional biases, refine execution, and achieve consistent results.

Trade with Clarity and Win With Confidence Using ChartPros Free NeuroTrading Method Quick Start Guide

Here's just one example of the powerful benefits traders get for free from ChartPros!

Chart UPDATE for UnitedHealth Group (UNH)

Price Bounced Hard Off Anticipated Level...

"Dead Cat Bounce" or a rally with legs?

Charter’s $21.9B Power Play: Breakout or Bull Trap?

Charter surged on news of its Cox Communications acquisition, a rare move for an acquiring firm. 

But is this a real breakout or just a fake out? 

The chart may have the answer...